Evidence map›Paper›PMID 32042107›Full record

ArticleScientific reports2020

Differences in Transcriptional Dynamics Between T-cells and Macrophages as Determined by a Three-State Mathematical Model.

Catherine DeMarino, Maria Cowen, Michelle L Pleet, Daniel O Pinto, Pooja Khatkar, James Erickson, Steffen S Docken, Nicholas Russell, Blake Reichmuth, Tin Phan and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency Virus.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Trial
  2. Article
  3. Review
  4. HIV-1 Transcription Inhibition Using Small RNA-Binding Molecules.Pharmaceuticals (Basel, Switzerland) · 2023
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Catherine DeMarinoLaboratory of Molecular Virology, School of Systems Biology, George Mason University, Manassas, VA, USA.
Maria CowenLaboratory of Molecular Virology, School of Systems Biology, George Mason University, Manassas, VA, USA.
Michelle L PleetLaboratory of Molecular Virology, School of Systems Biology, George Mason University, Manassas, VA, USA.
Daniel O PintoLaboratory of Molecular Virology, School of Systems Biology, George Mason University, Manassas, VA, USA.
Pooja KhatkarLaboratory of Molecular Virology, School of Systems Biology, George Mason University, Manassas, VA, USA.
James EricksonLaboratory of Molecular Virology, School of Systems Biology, George Mason University, Manassas, VA, USA.
Steffen S DockenDepartment of Mathematics, University of California Davis, Davis, CA, USA.
Nicholas RussellDepartment of Mathematical Sciences, University of Delaware, Newark, DE, USA.ORCID http://orcid.org/0000-0001-9174-685X
Blake ReichmuthDepartment of Mathematical Sciences, George Mason University, Fairfax, VA, USA.ORCID http://orcid.org/0000-0003-1752-1665
Tin PhanSchool of Mathematical and Statistical Sciences, Arizona State University, Tempe, AZ, USA.
Yang KuangSchool of Mathematical and Statistical Sciences, Arizona State University, Tempe, AZ, USA.
Daniel M AndersonDepartment of Mathematical Sciences, George Mason University, Fairfax, VA, USA. danders1@gmu.edu.
Maria EmelianenkoDepartment of Mathematical Sciences, George Mason University, Fairfax, VA, USA. memelian@gmu.edu.
Fatah KashanchiLaboratory of Molecular Virology, School of Systems Biology, George Mason University, Manassas, VA, USA. fkashanc@gmu.edu.
George Mason University · USArizona State University · USUniversity of California, Davis · USUniversity of Delaware · US

Funding

HIV1 INHIBITION USING TAT PEPTIDE DERIVATIVESR01AI043894 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI KASHANCHI, FATAH · 1999 to 2015
$4.4M
HIV neuropathogenesis related to exosomes containing HIV non-coding RNAsR01NS099029 · NINDS · GEORGE MASON UNIVERSITY · PI KASHANCHI, FATAH · 2016 to 2020
$1.9M
Effect of chromatin remodelers/modifiers on HIV-1 Tat activated transcriptionR21AI074410 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI KASHANCHI, FATAH · 2009 to 2010
$432k
A radiation-induced cellular stress activates HIV and induces killing of infected cellsR21AI127351 · NIAID · GEORGE MASON UNIVERSITY · PI KASHANCHI, FATAH · 2016 to 2017
$418k
HIV-1 TAR derived miRNA: Implications for Latency and PathogenesisR21AI078859 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI KASHANCHI, FATAH · 2009 to 2010
$400k
The Effect of Antiretroviral Drugs on Exosome Release and Associated CNS DysfunctionF31NS109443 · NINDS · GEORGE MASON UNIVERSITY · PI DEMARINO, CATHERINE · 2019 to 2019
$22k
NIAID NIH HHS R01 AI043894NIAID NIH HHS R21 AI074410NIAID NIH HHS R21 AI078859NIAID NIH HHS R21 AI127351NINDS NIH HHS F31 NS109443NINDS NIH HHS R01 NS099029
6 · The paper itself

Abstract

HIV-1 viral transcription persists in patients despite antiretroviral treatment, potentially due to intermittent HIV-1 LTR activation. While several mathematical models have been explored in the context of LTR-protein interactions, in this work for the first time HIV-1 LTR model featuring repressed, intermediate, and activated LTR states is integrated with generation of long (env) and short (TAR) RNAs and proteins (Tat, Pr55, and p24) in T-cells and macrophages using both cell lines and infected primary cells. This type of extended modeling framework allows us to compare and contrast behavior of these two cell types. We demonstrate that they exhibit unique LTR dynamics, which ultimately results in differences in the magnitude of viral products generated. One of the distinctive features of this work is that it relies on experimental data in reaction rate computations. Two RNA transcription rates from the activated promoter states are fit by comparison of experimental data to model predictions. Fitting to the data also provides estimates for the degradation/exit rates for long and short viral RNA. Our experimentally generated data is in reasonable agreement for the T-cell as well macrophage population and gives strong evidence in support of using the proposed integrated modeling paradigm. Sensitivity analysis performed using Latin hypercube sampling method confirms robustness of the model with respect to small parameter perturbations. Finally, incorporation of a transcription inhibitor (F07#13) into the governing equations demonstrates how the model can be used to assess drug efficacy. Collectively, our model indicates transcriptional differences between latently HIV-1 infected T-cells and macrophages and provides a novel platform to study various transcriptional dynamics leading to latency or activation in numerous cell types and physiological conditions.

Indexed as

Anti-HIV AgentsCell LineDrug Resistance, ViralGene Expression Regulation, ViralHIV-1HIV InfectionsHIV Long Terminal RepeatHumansMacrophagesModels, GeneticModels, ImmunologicalPrimary Cell CultureRNA, ViralT-LymphocytesTranscription, GeneticVirus ReplicationAnti-HIV AgentsRNA, Viral

Identifiers

PMID32042107
PMCPMC7010665
OpenAlexW3005032614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.